Carbonic Anhydrases

Download PDF

Recent Publications on Carbonic Anhydrases:
Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma. OBJECTIVE: Low-dose-rate (LDR) brachytherapy is an effective treatment for...	9th July, 2008		J Clin Oncol. 2008 Jun 20;26(18):3105-7; author reply 3107-9. DOI Direct Link
Brachytherapy for oral tongue cancer: an analysis of treatment results with various biological markers. OBJECTIVE: Low-dose-rate (LDR) brachytherapy is an effective treatment for...	8th July, 2008	Department of Radiology, Sapporo Medical University, School of Medicine,	Jpn J Clin Oncol. 2008 Jun;38(6):402-7. DOI Direct Link
Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited-old leads for new applications? Sulfonamide diuretics such as hydrochlorothiazide, hydroflumethiazide,...	5th July, 2008	Universita degli Studi di Firenze, Laboratorio di Chimica Bioinorganica,	Org Biomol Chem. 2008 Jul 21;6(14):2499-506. Epub 2008 May 29. DOI Direct Link
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma. We attempted to describe, in a series of clear cell renal cell carcinoma...	14th June, 2008	CNRS UMR6061 Genetics and development, IFR 140, University of Rennes 1,	Int J Cancer. 2008 Jul 15;123(2):395-400. DOI Direct Link
Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. The expression of carbonic anhydrase XII (CA12), a gene that encodes a...	11th June, 2008	Department of Cell and Developmental Biology, College of Medicine,	Cancer Res. 2008 May 1;68(9):3505-15. DOI Direct Link
→View more research publications.

BioNews Results for Carbonic Anhydrases:
Learn about the World Ophthalmic Pharmaceutical Drugs Market	Market Wire:  Jun 27 2008 9:48PM Matching: carbonic
Learn about the World Ophthalmic Pharmaceutical Drugs Market	Street Insider:  Jun 27 2008 8:51PM Matching: carbonic

Carbonic Anhydrases Clinical Trials:
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension	Open-Angle Glaucoma;   Ocular Hypertension
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension	Open-Angle Glaucoma;   Ocular Hypertension
MK0507A Phase III Double-Blind, Comparative Study	Glaucoma Interventions: Drug: dorzolamide hydrochloride (+) timolol maleate;   Drug: Comparator: timolol maleate;   Drug: Comparator: dorzolamide hydrochloride
Lumigan Versus Cosopt	Open-Angle Glaucoma
Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan	Open Angle Glaucoma;   Ocular Hypertension;   Pseudoexfoliation Syndrome
→View more trials.

Carbonic Anhydrases Patents:
US Patent No.	Title
6531502	3-Methylidenyl-2-indolinone modulators of protein kinase
6803379	PHARMACOLOGICAL AGENTS AND METHODS OF TREATMENT THAT INACTIVATE PATHOGENIC PROKARYOTIC AND EUKARYOTIC CELLS AND VIRUSES BY ATTACKING HIGHLY CONSERVED DOMAINS IN STRUCTURAL METALLOPROTEIN AND METALLOENZYME TARGETS
6821997	Therapeutic and prophylactic treatment of aging and disorders of aging in humans
6855730	3-methylidenyl-2-indolinone modulators of protein kinase
6922586	Method and system for detecting electrophysiological changes in pre-cancerous and cancerous tissue
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Carbonic Anhydrases scientists - we have details of around 540 individuals working on Carbonic Anhydrases .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.